Novo Nordisk A/S - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US6701002056
35,82 € ↓ -1,80 (-4,78%)
2026-06-05
DEL PRIS
SecurityDE:NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionBnp Paribas Arbitrage, Sa
Latest Disclosed Ownership787,600 shares
Latest Disclosed Value $ 28,944,300
Bnp Paribas Arbitrage, Sa ownership in NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On May 12, 2026 - Bnp Paribas Arbitrage, Sa filed a 13F-HR form disclosing ownership of 787,600 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (DE:NOVA) valued at $24,848,780 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 1,398,292 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). This represents a change in shares of -43.67% during the quarter. The current value of the position is $28,211,832 USD.

Bnp Paribas Arbitrage, Sa has a history of taking positions in derivatives of the underlying security (NOVA) in the form of stock options. The firm currently holds call options representing 2,453 of underlying shares valued at $9,014,775 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F Novo Nordisk AS Equity 670100205 787,600 -610,692 -43.67 28,944 -59.32 0.0014
2026-02-10 2025-12-31 13F Novo Nordisk A S Equity 670100205 1,398,292 718,922 105.82 71,145 88.72 0.0322
2025-11-13 2025-09-30 13F Novo Nordisk A S Equity 670100205 679,370 89,616 15.20 37,698 -7.39 0.0201
2025-08-14 2025-06-30 13F Novo Nordisk Equity 670100205 589,754 -478,162 -44.78 40,705 -45.11 0.0233
2025-05-14 2025-03-31 13F Novo Nordisk A S Equity 670100205 1,067,916 487,392 83.96 74,156 48.50 0.0436
2025-02-14 2024-12-31 13F Novo Nordisk A S Equity 670100205 580,524 282,541 94.82 49,937 40.74 0.0280
2024-11-13 2024-09-30 13F Novo Nordisk Equity 670100205 297,983 208,466 232.88 35,481 177.69 0.0238
2024-08-13 2024-06-30 13F Novo Nordisk A S Equity 670100205 89,517 -334,410 -78.88 12,778 -76.53 0.0104
2024-05-01 2024-03-31 13F Novo Nordisk A S Equity 670100205 423,927 348,291 460.48 54,432 595.71 0.0478
2024-02-14 2023-12-31 13F/A-2 Novo Nordisk A S Equity 670100205 75,636 40,167 113.25 7,825 142.60 0.0089
2024-02-07 2023-12-31 13F/A-1 Novo Nordisk A S Equity 670100205 75,636 40,167 7,825 0.0011
2024-02-07 2023-12-31 13F Novo Nordisk A S Equity 670100205 75,636 7,825
2023-11-14 2023-09-30 13F Novo Nordisk A S Equity 670100205 35,469 -155,060 -81.38 3,226 -89.54 0.0041
2023-08-09 2023-06-30 13F Novo Nordisk A S Equity 670100205 190,529 190,133 48,013.38 30,833 48,841.27 0.0386
2023-05-12 2023-03-31 13F NOVO NORDISK A S EQUITY 670100205 396 -28,101 -98.61 63 -98.37 0.0001
2023-02-14 2022-12-31 13F Novo Nordisk A S Equity 670100205 28,497 -56,592 -66.51 3,857 -54.51 0.0059
2022-11-16 2022-09-30 13F/A-1 Novo Nordisk A Equity 670100205 85,089 2,883 3.51 8,477 -7.46 0.0136
2022-11-15 2022-09-30 13F Novo Nordisk A Equity 670100205 85,089 2,883 8,477 0.0020
2022-08-12 2022-06-30 13F Novo Nordisk A S Equity 670100205 82,206 81,886 25,589.38 9,160 26,071.43 0.0143
2022-05-18 2022-03-31 13F/A-1 Novo Nordisk A S Equity 670100205 320 0 0.00 36 0.00 0.0000
2022-02-09 2021-12-31 13F NOVO NORDISK A EQUITY 670100205 320 -27 -7.78 36 6.06 0.0001
2021-11-16 2021-09-30 13F/A-1 NOVO NORDISK A EQUITY 670100205 347 0 0.00 33 13.79 0.0000
2021-11-12 2021-09-30 13F NOVO NORDISK A EQUITY 670100205 700 353 49 0.0000
2021-08-10 2021-06-30 13F NOVO NORDISK A EQUITY 670100205 347 -202 -36.79 29 -21.62 0.0000
2021-05-07 2021-03-31 13F NOVO NORDISK A EQUITY 670100205 549 101 22.54 37 19.35 0.0001
2021-02-10 2020-12-31 13F NOVO NORDISK A EQUITY 670100205 448 -252 -36.00 31 -35.42 0.0001
2020-10-30 2020-09-30 13F NOVO NORDISK A EQUITY 670100205 700 -107 -13.26 49 -7.69 0.0001
2020-08-06 2020-06-30 13F NOVO NORDISK A EQUITY 670100205 807 -8,593 -91.41 53 -90.80 0.0001
2020-05-13 2020-03-31 13F NOVO NORDISK A EQUITY 670100205 9,400 7,714 457.53 566 482.47 0.0012
2020-02-12 2019-12-31 13F NOVO NORDISK A EQUITY 670100205 1,686 623 58.61 98 79.63 0.0002
2019-11-07 2019-09-30 13F NOVO NORDISK A EQUITY 670100205 1,063 -54 -4.83 55 -5.26 0.0001
2019-07-30 2019-06-30 13F NOVO NORDISK A EQUITY 670100205 1,117 -246 -18.05 57 -19.72 0.0001
2019-04-25 2019-03-31 13F NOVO NORDISK A EQUITY 670100205 1,363 44 3.34 71 18.33 0.0002
2019-02-12 2018-12-31 13F NOVO NORDISK A EQUITY 670100205 1,319 -46 -3.37 61 -6.25 0.0001
2018-11-07 2018-09-30 13F NOVO NORDISK A EQUITY 670100205 1,365 -147 -9.72 64 -7.25 0.0001
2018-07-25 2018-06-30 13F NOVO NORDISK A EQUITY 670100205 1,512 -382 -20.17 70 -25.81 0.0001
2018-05-11 2018-03-31 13F NOVO NORDISK A EQUITY 670100205 1,894 486 34.52 93 24.00 0.0002
2018-03-05 2017-12-31 13F/A-1 NOVO NORDISK A EQUITY 670100205 1,408 -261 -15.64 76 -6.25 0.0001
2018-02-01 2017-12-31 13F NOVO NORDISK A EQUITY 670100205 1,408 -261 76
2017-11-03 2017-09-30 13F NOVO-NORDISK A S ADR STOCK 670100205 1,669 57 3.54 80 15.94 0.0002
2017-08-03 2017-06-30 13F NOVO-NORDISK A S ADR STOCK 670100205 1,612 -65 -3.88 69 21.05 0.0002
2017-05-03 2017-03-31 13F NOVO-NORDISK A S ADR STOCK 670100205 1,677 141 9.18 57 3.64 0.0002
2017-02-14 2016-12-31 13F NOVO-NORDISK A S ADR STOCK 670100205 1,536 -389 -20.21 55 -31.25 0.0003
2016-10-05 2016-09-30 13F * NOVO-NORDISK A S ADR STOCK 670100205 1,925 828 75.48 80 37.93 0.0003
2016-07-06 2016-06-30 13F * NOVO-NORDISK A S ADR STOCK 670100205 1,097 289 35.77 59 34.88 0.0003
2016-04-22 2016-03-31 13F * NOVO-NORDISK A S ADR STOCK 670100205 808 -170 -17.38 44 -23.21 0.0002
2016-04-19 2015-12-31 13F/A-1 * NOVO-NORDISK A S ADR STOCK 670100205 978 -104 -9.61 57 -3.45 0.0003
2016-02-10 2015-12-31 13F * NOVO-NORDISK A S ADR STOCK 670100205 978 57
2015-11-13 2015-09-30 13F * NOVO-NORDISK A S ADR STOCK 670100205 1,082 -94 -7.99 59 -9.37 0.0001
2015-08-14 2015-06-30 13F NOVO-NORDISK A S ADR STOCK 670100205 1,176 1,176 -31.63 64 -99.98 0.0002
2013-11-13 2013-09-30 13F NOVO-NORDISK A S STOCK 670100205 0 -1,720 -100.00 0 -100.00
2013-08-13 2013-06-30 13F NOVO-NORDISK A S STOCK 670100205 1,720 1,720 267 0.0002
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-12 2026-03-31 13F Novo Nordisk AS Option Call 2,453 -1.88 9,015 -29.14 n/a n/a n/a
2026-02-10 2025-12-31 13F Novo Nordisk A S Option Call 2,500 -16.67 12,720 -23.59 n/a n/a n/a
2025-11-13 2025-09-30 13F Novo Nordisk A S Option Call 3,000 1,100.00 16,647 865.04 n/a n/a n/a
2025-08-14 2025-06-30 13F Novo Nordisk Option Call 250 -78.15 1,726 -78.28 n/a n/a n/a
2025-05-14 2025-03-31 13F Novo Nordisk A S Option Call 1,144 7,944 n/a n/a n/a
2025-02-14 2024-12-31 13F Novo Nordisk Option Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-13 2024-09-30 13F Novo Nordisk Option Call 2,000 66,566.67 23,814 56,600.00 n/a n/a n/a
2024-08-13 2024-06-30 13F Novo Nordisk A S Option Call 3 -99.61 43 -99.57 n/a n/a n/a
2024-05-01 2024-03-31 13F Novo Nordisk A S Option Call 762 127.46 9,784 182.37 n/a n/a n/a
2024-02-07 2023-12-31 13F/A Novo Nordisk A S Option Call 335 3,466 n/a n/a n/a
2024-02-14 2023-12-31 13F/A Novo Nordisk A S Option Call 335 3,466 n/a n/a n/a
2024-02-07 2023-12-31 13F Novo Nordisk A S Option Call 335 3,466 n/a n/a n/a
2023-05-12 2023-03-31 13F Novo Nordisk A S Option Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-14 2022-12-31 13F Novo Nordisk A S Option Call 1 0.00 14 44.44 n/a n/a n/a
2022-11-16 2022-09-30 13F/A Novo Nordisk A Option Call 1 0.00 10 -18.18 n/a n/a n/a
2022-11-15 2022-09-30 13F Novo Nordisk A Option Call 1 10 n/a n/a n/a
2022-08-12 2022-06-30 13F Novo Nordisk A S Option Call 1 11 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-10 2025-12-31 13F Novo Nordisk A S Option Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-13 2025-09-30 13F Novo Nordisk A S Option Put 146 810 n/a n/a n/a
2025-08-14 2025-06-30 13F Novo Nordisk A S Option Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-14 2025-03-31 13F Novo Nordisk A S Option Put 2,273 15,784 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.